For the geography segment; regional supply, demand, major players, and price is presented from 2019 to 2029.
This report covers the following regions:
- North America
- South America
- Asia & Pacific
- Europe
- MEA
For the competitor segment, the report includes global key players of Pharm CRO as well as some small players.
The information for each competitor includes:
- Company Profile
- Business Information
- SWOT Analysis
- Revenue, Gross Margin and Market Share
Applications Segment
- Central Lab
- Preclinical
- Phase I
- Phase II to Phase IV
- Other Severice
Companies Covered
- INC Research
- Quintiles
- PRA Health
- ICON
- Charles River Labs
- IQVIA
- Laboratory Corporation of America Holdings
- Medpace Holdings
- PAREXEL International Corporation
- Syneos Health
- EPS
- CMIC
- PPD
- Covance
Historical Data: from 2019 to 2023
Forecast Data: from 2024 to 2029
This product will be delivered within 1-3 business days.
Table of Contents
Companies Mentioned
- INC Research
- Quintiles
- PRA Health
- ICON
- Charles River Labs
- IQVIA
- Laboratory Corporation of America Holdings
- Medpace Holdings
- PAREXEL International Corporation
- Syneos Health
- EPS
- CMIC
- PPD
- Covance
- Parexel
- InVentiv Health
- Chiltern
- Wuxi AppTec
- Pharmaron
- Tigermed
- Nanjing Huawe
- Guangzhou Boji
- JOINN
- IQVIA Holdings Inc.
- PAREXEL International Corporation
- Pharmaceutical Product Development LLC
- Syneos Health
- Pra Health Sciences

